ShiraTronics announced that it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation ...

Edwards Lifesciences (NYSE:EW) today announced its plans for significant growth as a purely structural heart company in 2025.

A hospital in Texas announced that its electrophysiologists completed the first U.S. cases with the Medtronic (NYSE:MDT) ...

Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray ...

InnoCare Urologics announced today that it received FDA 510(k) clearance for its novel urinary safety catheter.

Beacon Biosignals announced today that it received FDA authorization for a new update to its Dreem 3S wearable sleep ...

Haemonetics (NYSE:HAE) announced today that it agreed to sell its whole blood assets to GVS S.p.A for $67.1 million.

Philips (NYSE:PHG) today announced a collaboration with Mayo Clinic aimed at advancing MRI for cardiac applications through ...

Distalmotion today announced the first successful U.S. outpatient procedures with its Dexter surgical robot platform.

GE HealthCare (Nasdaq:GEHC) announced today that it submitted its CleaRecon DL technology for FDA 510(k) clearance.

Nonin CEO John Hastings said TruO2 OTC offers "equitable, medical-grade technology that is designed for accuracy across all ...

Nervonik announced today that it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device ...